Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
210.23
+2.28 (1.10%)
Feb 21, 2025, 4:00 PM EST - Market closed
Danaher Employees
Danaher had 63,000 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
63,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$378,968
Profits / Employee
$61,889
Market Cap
151.18B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 63,000 | 0 | - |
Dec 31, 2023 | 63,000 | -18,000 | -22.22% |
Dec 31, 2022 | 81,000 | 1,000 | 1.25% |
Dec 31, 2021 | 80,000 | 11,000 | 15.94% |
Dec 31, 2020 | 69,000 | 9,000 | 15.00% |
Dec 31, 2019 | 60,000 | -11,000 | -15.49% |
Dec 31, 2018 | 71,000 | 4,000 | 5.97% |
Dec 31, 2017 | 67,000 | 5,000 | 8.06% |
Dec 31, 2016 | 62,000 | -19,000 | -23.46% |
Dec 31, 2015 | 81,000 | 10,000 | 14.08% |
Dec 31, 2014 | 71,000 | 5,000 | 7.58% |
Dec 31, 2013 | 66,000 | 3,000 | 4.76% |
Dec 31, 2012 | 63,000 | 4,000 | 6.78% |
Dec 31, 2011 | 59,000 | 10,800 | 22.41% |
Dec 31, 2010 | 48,200 | 1,600 | 3.43% |
Dec 31, 2009 | 46,600 | -3,700 | -7.36% |
Dec 31, 2008 | 50,300 | 300 | 0.60% |
Dec 31, 2007 | 50,000 | 5,000 | 11.11% |
Dec 31, 2006 | 45,000 | 5,000 | 12.50% |
Dec 31, 2005 | 40,000 | 5,000 | 14.29% |
Dec 31, 2004 | 35,000 | 5,000 | 16.67% |
Dec 31, 2003 | 30,000 | 1,000 | 3.45% |
Dec 31, 2002 | 29,000 | 6,000 | 26.09% |
Dec 31, 2001 | 23,000 | -1,000 | -4.17% |
Dec 31, 2000 | 24,000 | 5,000 | 26.32% |
Dec 31, 1999 | 19,000 | 1,000 | 5.56% |
Dec 31, 1998 | 18,000 | 4,800 | 36.36% |
Dec 31, 1997 | 13,200 | 1,600 | 13.79% |
Dec 31, 1996 | 11,600 | 1,100 | 10.48% |
Dec 31, 1995 | 10,500 | 540 | 5.42% |
Dec 31, 1994 | 9,960 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
DHR News
- 1 day ago - Danaher Announces Appointment of Charles Lamanna to Danaher Board - PRNewsWire
- 1 day ago - Danaher Increases Quarterly Dividend - PRNewsWire
- 5 days ago - Danaher: Self-Inflicted Pessimism? - Seeking Alpha
- 8 days ago - All-In: The 23-Stock Six-Figure Dividend Portfolio I'm Betting My Future On - Seeking Alpha
- 12 days ago - Where I'd Put $10,000 Right Now - My Best Dividend Picks For Income And Growth - Seeking Alpha
- 23 days ago - Danaher Analysts Cut Their Forecasts After Downbeat Earnings - Benzinga
- 24 days ago - Danaher Corporation (DHR) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 24 days ago - Danaher misses quarterly profit estimates on weak biotech demand - Reuters